Virtu KCG Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.28M | Sell |
16,014
-15,786
| -50% | -$1.26M | 0.04% | 430 |
|
|
2017
Q1 | $1.63M | Buy |
31,800
+2,374
| +8% | +$122K | 0.05% | 348 |
|
|
2016
Q4 | $1.1M | Buy |
29,426
+4,370
| +17% | +$164K | 0.03% | 668 |
|
|
2016
Q3 | $1.7M | Buy |
25,056
+10,679
| +74% | +$724K | 0.04% | 375 |
|
|
2016
Q2 | $798K | Buy |
14,377
+1,013
| +8% | +$56.2K | 0.02% | 919 |
|
|
2016
Q1 | $839K | Buy |
+13,364
| New | +$839K | 0.02% | 705 |
|
|
2015
Q4 | – | Sell |
-17,737
| Closed | -$1.43M | – | 2909 |
|
|
2015
Q3 | $1.43M | Buy |
17,737
+15,490
| +689% | +$1.24M | 0.02% | 421 |
|
|
2015
Q2 | $269K | Sell |
2,247
-9,762
| -81% | -$1.17M | ﹤0.01% | 1785 |
|
|
2015
Q1 | $1.25M | Buy |
+12,009
| New | +$1.25M | 0.03% | 441 |
|
|
2014
Q3 | – | Sell |
-3,892
| Closed | -$246K | – | 2627 |
|
|
2014
Q2 | $246K | Sell |
3,892
-2,277
| -37% | -$144K | ﹤0.01% | 1907 |
|
|
2014
Q1 | $414K | Buy |
+6,169
| New | +$414K | 0.01% | 1187 |
|
|
2013
Q4 | – | Sell |
-3,154
| Closed | -$202K | – | 2529 |
|
|
2013
Q3 | $202K | Buy |
+3,154
| New | +$202K | ﹤0.01% | 2060 |
|